BRAF and hairy cell leukemia: On the one hand, recurrent mutations accompanying BRAF-V600E are found in a minority of patients with HCL (see discussion in next section), but on the other hand, pharmacologic blockade of BRAF-V600E in the established leukemic clone seems sufficient to erase several key specific traits of HCL.21,22